Question 1

Am I a good candidate for the JetStream Navitus treatment based on my current health?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions clinical trial (NCT01722877). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential risks and benefits of this treatment compared to my current options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions clinical trial (NCT01722877). Contact the study team or your healthcare provider for specific answers.

Question 3

How often will I need to come in for follow-up visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions clinical trial (NCT01722877). Contact the study team or your healthcare provider for specific answers.

Question 4

What should I expect during the procedure and recovery period?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions clinical trial (NCT01722877). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any specific medications or treatments I need to avoid while participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions clinical trial (NCT01722877). Contact the study team or your healthcare provider for specific answers.

Question 6

How will my progress be monitored after the treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the JetStream (JS) Atherectomy in Femoropopliteal In-Stent Restenotic Lesions clinical trial (NCT01722877). Contact the study team or your healthcare provider for specific answers.

What this study is about